Aggressive central nervous system demyelination in an adolescent

Reviews in Neurological Diseases

Volumn 2, Issue 1, 2005, Pages 35-38

  Solanky, Mukesh ^a   Van Engel, Daniel ^b   Wolansky, Leo ^a   Cook, Stuart D ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VALLEY HOSPITAL   (United States)

Author keywords

Adolescent; Cladribine; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; CEFTRIAXONE; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXYCYCLINE; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; MINOCYCLINE; MITOXANTRONE; STEROID;

ADOLESCENT; CASE REPORT; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYME DISEASE; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; REVIEW;

ADOLESCENT; CLADRIBINE; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 16344364141     PISSN: 15452913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Schumacker GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the Panel on the Evaluation of Experimental Trials of Therapy in Multiple Sclerosis. Ann N Y Acad Sci. 1965;122:552-568.
2. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
3. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-127.
4. Saven A, Piro L. Newer purine analogues for the treatment of hairy-cell leukemia. N Engl J Med. 1994;330:691-697.
5. Rice GP, Filippi M, Comi G. Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group. Neurology. 2000;54:1145-1155.
6. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial. Lancet. 2004;364:263-269.